search
Back to results

Egg Intervention During Pregnancy in Indonesia (PRECODE)

Primary Purpose

Weight Gain, Anemia, Iron Deficiency, Birth Weight

Status
Recruiting
Phase
Not Applicable
Locations
Indonesia
Study Type
Interventional
Intervention
Egg intervention
Sponsored by
SEAMEO Regional Centre for Food and Nutrition
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Weight Gain focused on measuring Egg, Pregnancy, Indonesia, Epigenetic, Growth, Child development

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Woman is between 16 and 20 weeks of pregnancy based on the date of the first day of her last menstrual period.
  • She is 18-40 years of age.
  • She is planning to remain in the study area over the next 30 months.
  • She is of Sasak ethnicity

Exclusion Criteria:

  • She is expecting multiple births.
  • She has a known egg allergy.

Sites / Locations

  • Aikmel, Sakra, and Sikur SubdistrictRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Observational cohort (control group)

Intervention group

Arm Description

In the observational cohort, pregnant mothers in the 2nd trimester (n=500) will be recruited and they will be followed up until their children are 24 months old. The control group women will receive standard intervention in the form of Ante Natal Care from village midwives (Polindes) or Puskesmas (IFA tablet, calcium tablet, nutrition counselling).

The intervention group women (n=153) will be provided one egg three times per week from recruitment (2nd trimester) until term along with the standard Ante Natal Care.

Outcomes

Primary Outcome Measures

Prevalence of stunting
Z-score of LAZ <-2 SD based on WHO 2006
Proportion of children 10-14 months with impaired fine and gross motor skills
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess fine and gross motor skills among children aged 10 to 14 months
Proportion of children 10-14 months with impaired expressive and receptive language
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess expressive and receptive language among children aged 10 to 14 months
Proportion of children 10-14 months with impaired behavior
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess behavior among children aged 10 to 14 months
Proportion of children 10-14 months with impaired executive function
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess executive function among children aged 10 to 14 months
Proportion of children 10-14 months with impaired empathy
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess empathy among children aged 10 to 14 months
Proportion of children 10-14 months with impaired problem solving
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess problem solving among children aged 10 to 14 months
Proportion of children 10-14 months with impaired attention
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess attention among children aged 10 to 14 months
Proportion of children 10-14 months with impaired social-emotional reactivity
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess social-emotional reactivity among children aged 10 to 14 months
Proportion of children 20-24 months with impaired motor development
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess motor development among children aged 20 to 24 months
Proportion of children 20-24 months with impaired cognition
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess cognition among children aged 20 to 24 months
Proportion of children 20-24 months with impaired language
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess language among children aged 20 to 24 months
Proportion of children 20-24 months with impaired social-emotional development
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess social-emotional development among children aged 20 to 24 months
Scores of CDI vocabulary comprehension scale in children 10-12 months
MacArthur-Bates Communicative Development Inventories (CDI) is used to assess vocabulary comprehension scale among children aged 10 to 12 months
Scores of CDI vocabulary production scale in children 10-12 months
MacArthur-Bates Communicative Development Inventories (CDI) is used to assess vocabulary production among children aged 10 to 12 months
Epigenetic state of genes associated with stunting
Genome-wide analysis of epigenetic states using the Illumina Infinium Methylation EPIC 850k Bead Chip (EPIC array) will be performed for selected samples from the core cohort. The outcomes will be the epigenetic state of a large number of genes which are associated with child stunting.
Epigenetic markers of birth anthropometry, adult stature, metabolic state, and cognitive ability
All samples (newborn, children 24 mo, parents) will be analyzed using Next Generation Bisulphite Amplicon Sequencing (BSAS) from Illumina MiSeq platform in targeted regions of the genome. The outcomes will be profiles of specific epigenetic markers of birth anthropometry, adult stature, metabolic state, and cognitive ability.

Secondary Outcome Measures

Weight gain during pregnancy
All measurements will be taken to the nearest 0.1 kg using standard procedures with SECA weighing machine.
Birth weight
All measurements will be taken to the nearest 0.1 kg using standard procedures with SECA weighing machine.
Birth length
All measurements will be taken to the nearest milimeter using standard procedures with SECA stadiometer/infantometer.
Hemoglobin concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their hemoglobin.
Serum ferritin concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum ferritin
Serum transferrin receptor concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum transferrin receptor
Serum zinc concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum zinc
Serum retinol concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum retinol
RBC folate concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their RBC folate
Serum vitamin B12 concentration
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B12
RBC fatty acids concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their RBC fatty acids
Serum essential amino acids concentration
Nutritional status measured by biochemical assessment to the mothers for their serum essential amino acids
Serum methylmalonic acid concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum methylmalonic acid
Serum choline concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum choline
Serum betaine concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum betaine
Serum vitamin B2 concentration
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B2
Serum vitamin B6 concentration
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B6
Serum vitamin D concentration
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin D
Serum CRP concentration
Subclinical inflammation will be measured by serum CRP in pregnant mothers and children
Serum AGP concentration
Subclinical inflammation will be measured by serum AGP in pregnant mothers and children
Serum RBP concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum RBP
Serum hepcidine concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum hepcidine
Serum homocysteine concentration
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum homocysteine
Serum HbA1C concentration
Gestational diabetes status will be assesed to the mothers for their serum HbA1C
Fecal myeloperoxidase (MPO)
Gut inflammation from fecal will be measured by faecal myeloperoxidase (MPO) using ELISA
Fecal α1-antitrypsin (AAT)
Gut inflammation from fecal will be measured by fecal α1-antitrypsin (AAT) using ELISA
Soil-transmitted helminths infection
Fecal parasites from fecal will be assesed by Kato Katz and confirmed by qPCR
Bacteria infection
Type of bacteria (Salmonella, Shigella) from fecal will be assesed by culture method
Gut microbiota
Gut microbiota species (EPEC, ETEC, EHEC, EIEC) from fecal will be assesed using qPCR
Gut microbiome
Faecal microbiome would be analyzed using 16S RNA sequencing of the V4 region on the Illumina MiSeq and BSAS.
Intestinal fatty acid binding protein
Intestinal fatty acid binding protein from serum will be measured using ELISA

Full Information

First Posted
December 22, 2020
Last Updated
March 17, 2021
Sponsor
SEAMEO Regional Centre for Food and Nutrition
Collaborators
London School of Hygiene and Tropical Medicine, University of Aberdeen, University of Brighton, University College, London, Royal Veterinary College, Birkbeck, University of London, The International Livestock Research Institute (ILRI), Cheikh Anta Diop University, Senegal, National Institute of Nutrition, India, International Centre for Research in Agroforestry, Science Made Simple, Liverpool School of Tropical Medicine, International Initiative for Impact Evaluation, Digital Green Foundation, SOAS, University of London, University of Sheffield
search

1. Study Identification

Unique Protocol Identification Number
NCT04694235
Brief Title
Egg Intervention During Pregnancy in Indonesia
Acronym
PRECODE
Official Title
Effect on Pregnancy Outcomes, Infant Growth and Development of an Egg Intervention During Pregnancy in Indonesia
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Recruiting
Study Start Date
February 12, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
SEAMEO Regional Centre for Food and Nutrition
Collaborators
London School of Hygiene and Tropical Medicine, University of Aberdeen, University of Brighton, University College, London, Royal Veterinary College, Birkbeck, University of London, The International Livestock Research Institute (ILRI), Cheikh Anta Diop University, Senegal, National Institute of Nutrition, India, International Centre for Research in Agroforestry, Science Made Simple, Liverpool School of Tropical Medicine, International Initiative for Impact Evaluation, Digital Green Foundation, SOAS, University of London, University of Sheffield

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study consists of two arms: 1) intervention group using eggs as supplementary food given from 2nd trimester of pregnancy to birth, and 2) observational group of pregnant mothers. it aims to assess the effectiveness of improving dietary quality during pregnancy on the epigenetic and stunting related outcomes (growth and development) in infants, who will be followed up until 24 months old
Detailed Description
The study aims to assess the impact of improving dietary quality during pregnancy on the epigenetic and stunting related outcomes in infants. The open-label intervention study would be conducted alongside the observational study in the same study setting by recruitment of additional number (n=153) of pregnant women. Thus, a total of 653 pregnant women would be enrolled in the study; 153 women would be randomized to intervention arm and 500 to the control arm who would form an observational cohort of women and newborns as described above. The intervention group women will be provided one egg three times per week from recruitment (2nd trimester) until term. The control group women will receive standard intervention in the form of Ante Natal Care from village midwives or Public Health Centre (IFA tablet, calcium tablet, nutrition counselling).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Gain, Anemia, Iron Deficiency, Birth Weight, Birth Length, Child Development, Zinc Deficiency, Folate Deficiency, B12 Deficiency Vitamin, Amino Acid Deficiency, Mineral Deficiency, Vitamin A Deficiency, Fatty Acid Deficiency, Parasite Infestation, E. Coli Infection, Salmonella Infections, Shigella Infection, Protozoan Infections
Keywords
Egg, Pregnancy, Indonesia, Epigenetic, Growth, Child development

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A total of 653 pregnant women will be recruited from 40 villages in three sub-districts. Pregnant women will be randomly allocated into the intervention or control groups. Pregnant women in the intervention group will receive boiled eggs three times per week from 2nd trimester (16-20 weeks) until delivery.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
653 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Observational cohort (control group)
Arm Type
No Intervention
Arm Description
In the observational cohort, pregnant mothers in the 2nd trimester (n=500) will be recruited and they will be followed up until their children are 24 months old. The control group women will receive standard intervention in the form of Ante Natal Care from village midwives (Polindes) or Puskesmas (IFA tablet, calcium tablet, nutrition counselling).
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
The intervention group women (n=153) will be provided one egg three times per week from recruitment (2nd trimester) until term along with the standard Ante Natal Care.
Intervention Type
Dietary Supplement
Intervention Name(s)
Egg intervention
Intervention Description
Eggs are boiled until the white and yolk are firm (ca. 8 minutes) to maintain quality and safety and ensure the eggs are safe for consumption.
Primary Outcome Measure Information:
Title
Prevalence of stunting
Description
Z-score of LAZ <-2 SD based on WHO 2006
Time Frame
birth until 24 months after delivery
Title
Proportion of children 10-14 months with impaired fine and gross motor skills
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess fine and gross motor skills among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired expressive and receptive language
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess expressive and receptive language among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired behavior
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess behavior among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired executive function
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess executive function among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired empathy
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess empathy among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired problem solving
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess problem solving among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired attention
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess attention among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 10-14 months with impaired social-emotional reactivity
Description
Oxford Neurodevelopment Assessment (OX-NDA) is used to assess social-emotional reactivity among children aged 10 to 14 months
Time Frame
10-14 months of age
Title
Proportion of children 20-24 months with impaired motor development
Description
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess motor development among children aged 20 to 24 months
Time Frame
20-24 months of age
Title
Proportion of children 20-24 months with impaired cognition
Description
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess cognition among children aged 20 to 24 months
Time Frame
20-24 months of age
Title
Proportion of children 20-24 months with impaired language
Description
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess language among children aged 20 to 24 months
Time Frame
20-24 months of age
Title
Proportion of children 20-24 months with impaired social-emotional development
Description
INTERGROWTH Neurodevelopment Assessment (INTER-NDA) is used to assess social-emotional development among children aged 20 to 24 months
Time Frame
20-24 months of age
Title
Scores of CDI vocabulary comprehension scale in children 10-12 months
Description
MacArthur-Bates Communicative Development Inventories (CDI) is used to assess vocabulary comprehension scale among children aged 10 to 12 months
Time Frame
10-12 months of age
Title
Scores of CDI vocabulary production scale in children 10-12 months
Description
MacArthur-Bates Communicative Development Inventories (CDI) is used to assess vocabulary production among children aged 10 to 12 months
Time Frame
10-12 months of age
Title
Epigenetic state of genes associated with stunting
Description
Genome-wide analysis of epigenetic states using the Illumina Infinium Methylation EPIC 850k Bead Chip (EPIC array) will be performed for selected samples from the core cohort. The outcomes will be the epigenetic state of a large number of genes which are associated with child stunting.
Time Frame
parents: 72 h after delivery; baby: 72 h after delivery, 24 month
Title
Epigenetic markers of birth anthropometry, adult stature, metabolic state, and cognitive ability
Description
All samples (newborn, children 24 mo, parents) will be analyzed using Next Generation Bisulphite Amplicon Sequencing (BSAS) from Illumina MiSeq platform in targeted regions of the genome. The outcomes will be profiles of specific epigenetic markers of birth anthropometry, adult stature, metabolic state, and cognitive ability.
Time Frame
parents: 72 h after delivery; baby: 72 h after delivery, 24 month
Secondary Outcome Measure Information:
Title
Weight gain during pregnancy
Description
All measurements will be taken to the nearest 0.1 kg using standard procedures with SECA weighing machine.
Time Frame
2nd trimester (16-20 weeks gestation) and 3rd trimester (28-32 weeks gestation) of pregnancy
Title
Birth weight
Description
All measurements will be taken to the nearest 0.1 kg using standard procedures with SECA weighing machine.
Time Frame
24 hours after birth
Title
Birth length
Description
All measurements will be taken to the nearest milimeter using standard procedures with SECA stadiometer/infantometer.
Time Frame
24 hours after birth
Title
Hemoglobin concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their hemoglobin.
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum ferritin concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum ferritin
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum transferrin receptor concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum transferrin receptor
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum zinc concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum zinc
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum retinol concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum retinol
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
RBC folate concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their RBC folate
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum vitamin B12 concentration
Description
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B12
Time Frame
Mothers: second and third trimester of pregnancy
Title
RBC fatty acids concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their RBC fatty acids
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum essential amino acids concentration
Description
Nutritional status measured by biochemical assessment to the mothers for their serum essential amino acids
Time Frame
Mothers: second and third trimester of pregnancy
Title
Serum methylmalonic acid concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum methylmalonic acid
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum choline concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum choline
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum betaine concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum betaine
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum vitamin B2 concentration
Description
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B2
Time Frame
Mothers: second and third trimester of pregnancy
Title
Serum vitamin B6 concentration
Description
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin B6
Time Frame
Mothers: second and third trimester of pregnancy
Title
Serum vitamin D concentration
Description
Nutritional status measured by biochemical assessment to the mothers for their serum vitamin D
Time Frame
Mothers: second and third trimester of pregnancy
Title
Serum CRP concentration
Description
Subclinical inflammation will be measured by serum CRP in pregnant mothers and children
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum AGP concentration
Description
Subclinical inflammation will be measured by serum AGP in pregnant mothers and children
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum RBP concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum RBP
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum hepcidine concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum hepcidine
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum homocysteine concentration
Description
Nutritional status measured by biochemical assessment to the mothers and children. Both the pregnant mothers and children will be measured for their serum homocysteine
Time Frame
Mothers: second and third trimester of pregnancy; children: 6 months (+/- 2 weeks) after delivery; breastmilk: 3 and 6 months (+/- 2 weeks) after delivery
Title
Serum HbA1C concentration
Description
Gestational diabetes status will be assesed to the mothers for their serum HbA1C
Time Frame
Mothers: second and third trimester of pregnancy
Title
Fecal myeloperoxidase (MPO)
Description
Gut inflammation from fecal will be measured by faecal myeloperoxidase (MPO) using ELISA
Time Frame
baby: 1, 6, 24 months of age
Title
Fecal α1-antitrypsin (AAT)
Description
Gut inflammation from fecal will be measured by fecal α1-antitrypsin (AAT) using ELISA
Time Frame
baby: 1, 6, 24 months of age
Title
Soil-transmitted helminths infection
Description
Fecal parasites from fecal will be assesed by Kato Katz and confirmed by qPCR
Time Frame
mothers: 3rd trimester (28-32 gestational weeks) of pregnancy; baby: 1, 6, 24 months of age
Title
Bacteria infection
Description
Type of bacteria (Salmonella, Shigella) from fecal will be assesed by culture method
Time Frame
baby: 1, 6, 24 months of age
Title
Gut microbiota
Description
Gut microbiota species (EPEC, ETEC, EHEC, EIEC) from fecal will be assesed using qPCR
Time Frame
baby: 1, 6, 24 months of age
Title
Gut microbiome
Description
Faecal microbiome would be analyzed using 16S RNA sequencing of the V4 region on the Illumina MiSeq and BSAS.
Time Frame
baby: 1, 6, 24 months of age
Title
Intestinal fatty acid binding protein
Description
Intestinal fatty acid binding protein from serum will be measured using ELISA
Time Frame
baby: 6 months of age

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Woman is between 16 and 20 weeks of pregnancy based on the date of the first day of her last menstrual period. She is 18-40 years of age. She is planning to remain in the study area over the next 30 months. She is of Sasak ethnicity Exclusion Criteria: She is expecting multiple births. She has a known egg allergy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Arienta RP Sudibya, M.Sc
Phone
+628118113811
Email
arientasudibya@seameo-recfon.org
First Name & Middle Initial & Last Name or Official Title & Degree
Nur L Zahra, M.Sc
Phone
+6285697754706
Email
nurlailatuzzahra@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Umi Fahmida, Dr.
Organizational Affiliation
SEAMEO RECFON
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aikmel, Sakra, and Sikur Subdistrict
City
Mataram
State/Province
West Nusa Tenggara
Country
Indonesia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Arienta RP Sudibya
Phone
+628118113811
Email
arientasudibya@seameo-recfon.org

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23425631
Citation
Boeke CE, Gillman MW, Hughes MD, Rifas-Shiman SL, Villamor E, Oken E. Choline intake during pregnancy and child cognition at age 7 years. Am J Epidemiol. 2013 Jun 15;177(12):1338-47. doi: 10.1093/aje/kws395. Epub 2013 Feb 20.
Results Reference
background
PubMed Identifier
29217669
Citation
Caudill MA, Strupp BJ, Muscalu L, Nevins JEH, Canfield RL. Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. FASEB J. 2018 Apr;32(4):2172-2180. doi: 10.1096/fj.201700692RR. Epub 2018 Jan 5.
Results Reference
background
PubMed Identifier
30412672
Citation
Clare CE, Brassington AH, Kwong WY, Sinclair KD. One-Carbon Metabolism: Linking Nutritional Biochemistry to Epigenetic Programming of Long-Term Development. Annu Rev Anim Biosci. 2019 Feb 15;7:263-287. doi: 10.1146/annurev-animal-020518-115206. Epub 2018 Nov 9.
Results Reference
background
PubMed Identifier
24028891
Citation
Haggarty P. Epigenetic consequences of a changing human diet. Proc Nutr Soc. 2013 Nov;72(4):363-71. doi: 10.1017/S0029665113003376. Epub 2013 Sep 13.
Results Reference
background
PubMed Identifier
23151531
Citation
Haggarty P, Hoad G, Campbell DM, Horgan GW, Piyathilake C, McNeill G. Folate in pregnancy and imprinted gene and repeat element methylation in the offspring. Am J Clin Nutr. 2013 Jan;97(1):94-9. doi: 10.3945/ajcn.112.042572. Epub 2012 Nov 14.
Results Reference
background
PubMed Identifier
24812310
Citation
Whitelaw N, Bhattacharya S, Hoad G, Horgan GW, Hamilton M, Haggarty P. Epigenetic status in the offspring of spontaneous and assisted conception. Hum Reprod. 2014 Jul;29(7):1452-8. doi: 10.1093/humrep/deu094. Epub 2014 May 8.
Results Reference
background
PubMed Identifier
30707743
Citation
Lorgen-Ritchie M, Murray AD, Ferguson-Smith AC, Richards M, Horgan GW, Phillips LH, Hoad G, Gall I, Harrison K, McNeill G, Ito M, Haggarty P. Imprinting methylation in SNRPN and MEST1 in adult blood predicts cognitive ability. PLoS One. 2019 Feb 1;14(2):e0211799. doi: 10.1371/journal.pone.0211799. eCollection 2019. Erratum In: PLoS One. 2019 Apr 10;14(4):e0215422.
Results Reference
background
PubMed Identifier
25741966
Citation
Masser DR, Stanford DR, Freeman WM. Targeted DNA methylation analysis by next-generation sequencing. J Vis Exp. 2015 Feb 24;(96):52488. doi: 10.3791/52488.
Results Reference
background
PubMed Identifier
23841827
Citation
Dighe MK, Frederick IO, Andersen HF, Gravett MG, Abbott SE, Carter AA, Algren H, Rocco DA, Waller SA, Sorensen TK, Enquobahrie D, Blakey I, Knight HE, Cheikh Ismail L; International Fetal and Newborn Growth Consortium for the 21st Century. Implementation of the INTERGROWTH-21st Project in the United States. BJOG. 2013 Sep;120 Suppl 2:123-8, v. doi: 10.1111/1471-0528.12126. Epub 2013 Jul 11.
Results Reference
background
Citation
Weisenberger D, Van Den Berg D, Pan F, Berman B, Laird P. Comprehensive DNA methylation analysis on the Illumina Infinium assay platform. Illumina, San Diego. 2008.
Results Reference
background
Citation
Fenson L, Pethick S, Renda C, Cox JL, Dale PS, Reznick JS. Short-form versions of the MacArthur communicative development inventories. Applied Psycholinguistics. 2000;21(1):95-116.
Results Reference
background
PubMed Identifier
12730414
Citation
Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003 May;133(5):1302-7. doi: 10.1093/jn/133.5.1302. Erratum In: J Nutr. 2003 Sep;133(9):2918.
Results Reference
background
Citation
Patterson KY, Bhagwat SA, Williams JR, Howe JC, Holden J, Zeisel S, et al. USDA database for the choline content of common foods, release two. Nutrient Data Laboratory, Beltsville Human Nutrition Research Center, ARS, USDA. 2008.
Results Reference
background
PubMed Identifier
16600945
Citation
Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, Willett WC. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr. 2006 Apr;83(4):905-11. doi: 10.1093/ajcn/83.4.905.
Results Reference
background
Citation
Mhila G, DeRenzi B, Mushi C, Wakabi T, Steele M, Dhaldialla P, et al. Using mobile applications for community-based social support for chronic patients. Health Informatics in Africa. 2009.
Results Reference
background
PubMed Identifier
31204503
Citation
Sethi V, Tiwari K, Sareen N, Singh S, Mishra C, Jagadeeshwar M, Sunitha K, Kumar SV, de Wagt A, Sachdev HPS. Delivering an Integrated Package of Maternal Nutrition Services in Andhra Pradesh and Telangana (India). Food Nutr Bull. 2019 Sep;40(3):393-408. doi: 10.1177/0379572119844142. Epub 2019 Jun 16.
Results Reference
background
Citation
Lutter CK, Iannotti LL, Stewart CP. Cracking the egg potential during pregnancy and lactation. Sight Life. 2016;30:75-81.
Results Reference
background
PubMed Identifier
29750367
Citation
Jacobson SW, Carter RC, Molteno CD, Stanton ME, Herbert JS, Lindinger NM, Lewis CE, Dodge NC, Hoyme HE, Zeisel SH, Meintjes EM, Duggan CP, Jacobson JL. Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Alcohol Clin Exp Res. 2018 Jul;42(7):1327-1341. doi: 10.1111/acer.13769. Epub 2018 Jun 15.
Results Reference
background
PubMed Identifier
22418088
Citation
Yan J, Jiang X, West AA, Perry CA, Malysheva OV, Devapatla S, Pressman E, Vermeylen F, Stabler SP, Allen RH, Caudill MA. Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans. Am J Clin Nutr. 2012 May;95(5):1060-71. doi: 10.3945/ajcn.111.022772. Epub 2012 Mar 14.
Results Reference
background

Learn more about this trial

Egg Intervention During Pregnancy in Indonesia

We'll reach out to this number within 24 hrs